Close

Publications

Boettiger, D; SALARIA, N; Batura, N; SCHELLENBERG, J; Francis, J; Mounier-Jack, S; WISEMAN, V;
2022
Health policy and planning, (2022).38 1 10.1093/heapol/czac087.
ZHENG, B; Green, AC A; TAZARE, J; Curtis, HJ; Fisher, L; Nab, L; SCHULTZE, A; MAHALINGASIVAM, V; PARKER, EP K; Hulme, WJ; Bacon, SC J; DeVito, NJ; Bates, C; Evans, D; Inglesby, P; Drysdale, H; Davy, S; Cockburn, J; Morton, CE; Hickman, G; Ward, T; Smith, RM; Parry, J; Hester, F; Harper, S; ... TOMLINSON, LA.
2022
BMJ (Clinical research ed.), (2022).379, 10.1136/bmj-2022-071932.
Chege, T; Wafula, F; Tama, E; KHAYONI, I; Ogira, D; Gitau, N; GOODMAN, C;
2022
BMC Health Services Research, (2022).22 1 10.1186/s12913-022-08727-3.
Mbau, R; OLIVER, K; VASSALL, A; GILSON, L; Barasa, E;
2022
Health policy and planning, (2022).38 1 10.1093/heapol/czac099.
Chauhan, AS; GUINNESS, L; Bahuguna, P; SINGH, MP; Aggarwal, V; Rajsekhar, K; Tripathi, S; Prinja, S;
2022
BMC health services research, (2022).22 1 10.1186/s12913-022-08707-7.
Musiega, A; Tsofa, B; Nyawira, L; Njuguna, RG; Munywoki, J; HANSON, K; Mulwa, A; Molyneux, S; Maina, I; Normand, C; Jemutai, J; Barasa, E;
2022
Health policy and planning, (2022).38 3 10.1093/heapol/czac098.
TB-PRACTECAL: the economic case for 24-week BPaL-based treatments for drug-resistant TB.
SWEENEY, S; Laurence, Y; Berry, C; Kazounis, E; Motta, I; DODD, M; FIELDING, K; Nyang'wa, B;
2022
(2022).
Green, N; Lamrock, F; NAYLOR, N; Williams, J; BRIGGS, A;
2022
PharmacoEconomics, (2022).41 1 10.1007/s40273-022-01199-7.
McEwan, P; Darlington, O; Miller, R; McMurray, JJ V; Wheeler, DC; Heerspink, HJ L; BRIGGS, A; Bergenheim, K; Garcia Sanchez, JJ;
2022
Clinical journal of the American Society of Nephrology, (2022).17 12 10.2215/CJN.03790322.